data_1kvg_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1kvg _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 . . . . . 0 N--CA 1.455 -0.204 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -93.93 137.2 33.4 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 169.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -149.21 -164.98 11.95 Favored Glycine 0 CA--C 1.531 1.031 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -177.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -52.28 -44.87 43.24 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 124.635 3.557 . . . . 0.0 113.637 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.9 mt -99.19 61.04 1.21 Allowed 'General case' 0 C--N 1.339 0.152 0 C-N-CA 123.605 0.762 . . . . 0.0 109.032 -175.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.69 -120.47 20.45 Favored Glycine 0 C--N 1.339 0.708 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 -84.83 127.76 34.29 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 172.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 66.9 t . . . . . 0 N--CA 1.456 -0.138 0 C-N-CA 124.91 1.284 . . . . 0.0 108.602 -174.777 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.7 p-80 . . . . . 0 N--CA 1.455 -0.185 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -80.76 140.79 35.33 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 172.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -151.24 -167.4 14.74 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -177.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.0 -34.07 39.52 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.408 2.739 . . . . 0.0 111.918 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.8 mt -99.1 60.46 1.2 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.4 -129.81 45.79 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 71.8 t-105 -85.2 109.92 18.65 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 68.6 t . . . . . 0 N--CA 1.455 -0.205 0 C-N-CA 124.764 1.225 . . . . 0.0 108.726 -175.418 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.3 p-80 . . . . . 0 CA--C 1.529 0.155 0 CA-C-O 120.734 0.302 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -85.4 122.51 29.66 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 171.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -139.81 -165.7 10.37 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.752 1.168 . . . . 0.0 110.716 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 99.5 Cg_exo -49.58 -48.26 19.7 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 124.865 3.71 . . . . 0.0 113.978 -176.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.2 mt -99.26 61.62 1.22 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.603 0.761 . . . . 0.0 109.075 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.36 -117.92 12.39 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 177.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 63.0 t-105 -87.36 97.53 10.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.2 t . . . . . 0 N--CA 1.455 -0.202 0 C-N-CA 125.096 1.359 . . . . 0.0 109.2 -174.795 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -73.77 92.91 2.06 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 173.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -92.92 -166.49 38.62 Favored Glycine 0 CA--C 1.532 1.109 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 173.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -63.63 -36.14 54.72 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.163 2.575 . . . . 0.0 111.829 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.8 mt -99.45 53.2 0.94 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.747 0.819 . . . . 0.0 109.579 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.83 -134.19 40.76 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -68.34 100.47 1.07 Allowed 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 117.37 0.585 . . . . 0.0 109.959 174.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 70.8 t . . . . . 0 N--CA 1.452 -0.349 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 173.924 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.7 p-80 . . . . . 0 N--CA 1.451 -0.382 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -71.99 128.68 36.49 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 176.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -149.64 -168.03 14.65 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.475 1.036 . . . . 0.0 110.543 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -50.4 -48.93 18.1 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 124.851 3.701 . . . . 0.0 113.759 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.3 mt -99.22 59.22 1.13 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.597 0.759 . . . . 0.0 109.084 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 65.67 -113.83 6.12 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 124.031 0.824 . . . . 0.0 111.109 176.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 39.6 t-105 -96.46 93.76 7.0 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.447 1.099 . . . . 0.0 108.621 -177.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 64.5 t . . . . . 0 C--O 1.226 -0.157 0 C-N-CA 125.076 1.35 . . . . 0.0 109.691 -169.87 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 . . . . . 0 CA--C 1.53 0.192 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -78.06 133.56 37.89 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 172.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -149.18 -163.61 11.08 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -51.69 -44.74 42.48 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 124.735 3.623 . . . . 0.0 113.779 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.5 mt -99.05 60.38 1.2 Allowed 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.545 0.738 . . . . 0.0 109.02 -176.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 62.01 -117.75 12.45 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -88.39 127.47 35.5 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 172.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 65.1 t . . . . . 0 N--CA 1.454 -0.272 0 C-N-CA 125.003 1.321 . . . . 0.0 108.761 -170.493 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 . . . . . 0 CA--C 1.528 0.129 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -73.88 94.8 2.35 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 174.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -103.57 -169.12 25.57 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.05 1.31 . . . . 0.0 110.612 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -64.17 -37.35 42.07 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 123.327 2.684 . . . . 0.0 111.693 -178.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 78.5 mt -99.43 54.7 0.96 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.725 0.81 . . . . 0.0 109.364 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.46 -125.92 18.18 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 174.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 49.5 t-105 -87.17 97.1 10.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 89.8 t . . . . . 0 N--CA 1.454 -0.226 0 C-N-CA 124.64 1.176 . . . . 0.0 109.042 -170.398 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.6 p-80 . . . . . 0 N--CA 1.458 -0.069 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -72.99 141.95 47.74 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.27 -163.43 15.03 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -176.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -51.93 -45.04 41.12 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 124.665 3.577 . . . . 0.0 113.592 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.8 mt -99.14 60.54 1.2 Allowed 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.659 0.784 . . . . 0.0 108.95 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.68 -128.71 48.3 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -80.66 116.39 20.65 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 170.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.8 t . . . . . 0 N--CA 1.451 -0.38 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -178.243 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.2 p-80 . . . . . 0 N--CA 1.456 -0.134 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -78.01 91.38 4.24 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -97.87 -165.96 31.7 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.065 1.317 . . . . 0.0 110.939 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -52.3 -45.31 40.29 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 124.643 3.562 . . . . 0.0 113.068 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 72.3 mt -99.4 52.44 0.94 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.854 0.862 . . . . 0.0 109.542 -177.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 65.67 -136.83 36.38 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 178.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -73.77 96.9 2.62 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.049 0.54 . . . . 0.0 110.436 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 83.9 t . . . . . 0 N--CA 1.454 -0.25 0 C-N-CA 125.323 1.449 . . . . 0.0 108.331 179.077 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.5 p-80 . . . . . 0 N--CA 1.456 -0.154 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -73.33 136.46 44.47 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -156.77 -165.02 14.17 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -176.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -50.82 -47.78 23.75 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 124.808 3.672 . . . . 0.0 113.678 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.8 mt -99.19 61.45 1.23 Allowed 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.46 -118.74 15.81 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 178.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -89.67 104.58 17.13 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.882 0.873 . . . . 0.0 109.428 175.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 64.7 t . . . . . 0 N--CA 1.453 -0.313 0 C-N-CA 125.328 1.451 . . . . 0.0 108.812 -176.166 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 39.8 p-80 . . . . . 0 N--CA 1.454 -0.244 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -91.09 135.48 33.73 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 171.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -152.91 -165.02 12.95 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -178.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -50.7 -45.92 32.82 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 124.893 3.729 . . . . 0.0 114.181 -176.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -98.94 65.93 1.53 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 59.58 -121.55 27.08 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 176.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -85.58 106.08 16.62 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 174.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.8 t . . . . . 0 N--CA 1.455 -0.187 0 C-N-CA 124.913 1.285 . . . . 0.0 108.832 -175.64 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.4 p-80 . . . . . 0 N--CA 1.452 -0.332 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -75.06 81.53 2.24 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.198 0.599 . . . . 0.0 109.798 177.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -89.88 -163.31 39.1 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.485 1.517 . . . . 0.0 110.754 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -66.53 -42.7 9.08 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.275 2.65 . . . . 0.0 111.625 -174.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 73.1 mt -99.51 49.47 0.94 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.796 0.838 . . . . 0.0 109.649 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 73.39 -128.72 11.71 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 176.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 36.9 t-105 -83.07 80.92 8.9 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.66 0.784 . . . . 0.0 109.995 -173.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.6 t . . . . . 0 C--N 1.339 0.15 0 C-N-CA 124.946 1.298 . . . . 0.0 109.453 -171.94 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.2 p-80 . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -73.85 123.44 24.22 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -135.61 -170.38 12.08 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.311 1.434 . . . . 0.0 110.198 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -65.5 -35.57 38.16 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.543 2.829 . . . . 0.0 112.34 -175.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -99.03 61.21 1.24 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 176.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 64.03 -115.29 7.73 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.163 0.887 . . . . 0.0 111.51 175.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 45.8 t-105 -98.24 93.84 6.45 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.416 1.086 . . . . 0.0 108.696 -177.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 96.4 t . . . . . 0 C--O 1.227 -0.124 0 C-N-CA 125.038 1.335 . . . . 0.0 109.487 -170.042 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -77.67 137.75 38.69 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -156.98 -164.21 13.31 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -178.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -50.87 -45.78 34.11 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 124.848 3.699 . . . . 0.0 113.861 -176.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.6 mt -99.08 61.58 1.25 Allowed 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -176.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.35 -121.21 25.87 Favored Glycine 0 C--N 1.34 0.756 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 178.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 65.2 t-105 -86.48 108.99 18.77 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 174.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.6 t . . . . . 0 N--CA 1.453 -0.295 0 C-N-CA 125.069 1.347 . . . . 0.0 108.849 -173.596 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 . . . . . 0 N--CA 1.457 -0.107 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -79.65 134.54 36.44 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 171.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -150.31 -164.4 11.85 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -177.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -52.21 -44.24 47.57 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 124.699 3.599 . . . . 0.0 113.678 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.9 mt -99.1 60.2 1.19 Allowed 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.617 0.767 . . . . 0.0 108.977 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.71 -119.18 17.2 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 62.5 t-105 -88.32 130.62 35.08 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 172.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.9 t . . . . . 0 N--CA 1.453 -0.292 0 C-N-CA 125.306 1.443 . . . . 0.0 108.782 -170.619 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 . . . . . 0 N--CA 1.456 -0.136 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -76.75 135.0 38.99 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 173.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -152.81 -163.72 11.9 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -177.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -51.73 -44.48 44.27 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 124.774 3.649 . . . . 0.0 113.762 -176.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.7 mt -99.05 60.31 1.2 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -176.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.96 -118.26 14.44 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 63.1 t-105 -88.8 126.29 35.28 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 172.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.2 t . . . . . 0 N--CA 1.454 -0.256 0 C-N-CA 125.263 1.425 . . . . 0.0 109.055 -170.005 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.1 p-80 . . . . . 0 N--CA 1.455 -0.219 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -77.25 97.55 4.86 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 171.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.49 -167.28 29.88 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.044 1.307 . . . . 0.0 110.512 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -65.12 -37.21 33.53 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.246 2.631 . . . . 0.0 111.609 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.1 mt -99.4 54.32 0.96 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.761 0.824 . . . . 0.0 109.482 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.39 -133.12 23.54 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 175.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 61.8 t-105 -80.53 96.01 6.67 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.5 t . . . . . 0 N--CA 1.456 -0.139 0 C-N-CA 124.907 1.283 . . . . 0.0 108.543 -175.922 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.7 p-80 . . . . . 0 N--CA 1.454 -0.238 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -77.12 97.1 4.63 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 172.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.63 -167.99 29.82 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.973 1.273 . . . . 0.0 110.539 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -64.93 -37.37 34.33 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.333 2.689 . . . . 0.0 111.602 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.2 mt -99.38 54.41 0.96 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.791 0.837 . . . . 0.0 109.486 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.39 -132.16 22.75 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 175.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -81.27 96.09 7.17 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 95.2 t . . . . . 0 N--CA 1.456 -0.157 0 C-N-CA 124.8 1.24 . . . . 0.0 108.542 -175.843 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 27.9 p-80 . . . . . 0 N--CA 1.454 -0.232 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -87.96 138.85 31.09 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 170.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -150.07 -168.25 15.04 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -65.84 -34.1 40.83 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.442 2.762 . . . . 0.0 112.369 -175.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -98.97 63.48 1.36 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 176.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.2 -128.08 43.63 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 176.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -84.34 105.98 15.59 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 175.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.1 t . . . . . 0 N--CA 1.455 -0.178 0 C-N-CA 124.651 1.18 . . . . 0.0 108.807 -176.319 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.9 p-80 . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -71.62 142.63 49.96 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.8 -163.7 16.09 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -176.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -51.98 -45.77 36.62 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 124.706 3.604 . . . . 0.0 113.546 -177.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 76.4 mt -99.19 61.28 1.22 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.673 0.789 . . . . 0.0 108.968 -176.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.97 -128.07 46.81 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -81.15 115.82 20.76 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 170.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 67.0 t . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -178.62 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.0 m . . . . . 0 N--CA 1.472 0.674 0 CA-C-O 119.654 -0.213 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 22.7 m -139.16 137.42 36.05 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.928 1.291 . . . . 0.0 108.406 174.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 -160.66 177.04 10.87 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.835 1.254 . . . . 0.0 109.366 -169.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -93.93 137.2 33.4 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 169.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -149.21 -164.98 11.95 Favored Glycine 0 CA--C 1.531 1.031 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -177.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -52.28 -44.87 43.24 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 124.635 3.557 . . . . 0.0 113.637 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.9 mt -99.19 61.04 1.21 Allowed 'General case' 0 C--N 1.339 0.152 0 C-N-CA 123.605 0.762 . . . . 0.0 109.032 -175.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.69 -120.47 20.45 Favored Glycine 0 C--N 1.339 0.708 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 -84.83 127.76 34.29 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 172.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 66.9 t -125.96 139.44 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 124.91 1.284 . . . . 0.0 108.602 -174.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 76.1 m -128.68 147.77 50.77 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.893 0.877 . . . . 0.0 109.232 175.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.0 mtpt -140.21 148.97 42.33 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.011 1.324 . . . . 0.0 108.884 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.077 0 O-C-N 122.335 -0.228 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 N--CA 1.474 0.727 0 N-CA-C 111.215 0.08 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.9 m -142.03 164.75 29.33 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.983 0.913 . . . . 0.0 110.01 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.7 p-80 -158.54 167.43 29.62 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.111 1.364 . . . . 0.0 108.935 -175.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -80.76 140.79 35.33 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 172.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -151.24 -167.4 14.74 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -177.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.0 -34.07 39.52 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.408 2.739 . . . . 0.0 111.918 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.8 mt -99.1 60.46 1.2 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.4 -129.81 45.79 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 71.8 t-105 -85.2 109.92 18.65 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 68.6 t -99.81 125.89 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 124.764 1.225 . . . . 0.0 108.726 -175.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 39.9 m -99.76 133.15 44.53 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.488 0.715 . . . . 0.0 109.968 175.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -88.46 66.55 8.31 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.811 1.244 . . . . 0.0 109.232 -172.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.065 0 CA-C-N 116.45 -0.341 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 N--CA 1.474 0.773 0 N-CA-C 111.828 0.306 . . . . 0.0 111.828 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 61.9 m -83.54 -175.82 6.0 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.97 0.908 . . . . 0.0 109.687 173.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.3 p-80 -147.49 168.92 20.7 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.621 0.769 . . . . 0.0 110.986 -169.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -85.4 122.51 29.66 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 171.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -139.81 -165.7 10.37 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.752 1.168 . . . . 0.0 110.716 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 99.5 Cg_exo -49.58 -48.26 19.7 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 124.865 3.71 . . . . 0.0 113.978 -176.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.2 mt -99.26 61.62 1.22 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.603 0.761 . . . . 0.0 109.075 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.36 -117.92 12.39 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 177.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 63.0 t-105 -87.36 97.53 10.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.2 t -99.77 132.69 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 125.096 1.359 . . . . 0.0 109.2 -174.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 96.6 m -99.66 144.03 29.21 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.058 0.943 . . . . 0.0 109.436 175.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.44 161.3 26.2 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.837 0.855 . . . . 0.0 110.886 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.063 0 O-C-N 122.21 -0.307 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.3 p . . . . . 0 N--CA 1.474 0.729 0 CA-C-O 120.347 0.118 . . . . 0.0 111.043 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 11.8 m -138.29 163.53 31.55 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.911 0.884 . . . . 0.0 110.156 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 -152.51 157.89 41.76 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.733 1.213 . . . . 0.0 109.303 -173.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -73.77 92.91 2.06 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 173.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -92.92 -166.49 38.62 Favored Glycine 0 CA--C 1.532 1.109 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 173.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -63.63 -36.14 54.72 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.163 2.575 . . . . 0.0 111.829 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.8 mt -99.45 53.2 0.94 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.747 0.819 . . . . 0.0 109.579 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.83 -134.19 40.76 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -68.34 100.47 1.07 Allowed 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 117.37 0.585 . . . . 0.0 109.959 174.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 70.8 t -99.46 125.44 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 173.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 95.0 m -99.83 139.34 35.63 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.967 0.907 . . . . 0.0 110.596 -177.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -155.72 91.11 1.27 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.075 0 O-C-N 122.186 -0.321 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.7 t . . . . . 0 N--CA 1.474 0.734 0 N-CA-C 111.347 0.129 . . . . 0.0 111.347 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.3 m -87.72 156.85 19.24 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.456 0.646 . . . . 0.0 110.414 169.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.7 p-80 -160.05 160.09 32.75 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.915 2.086 . . . . 0.0 107.125 -172.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -71.99 128.68 36.49 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 176.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -149.64 -168.03 14.65 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.475 1.036 . . . . 0.0 110.543 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -50.4 -48.93 18.1 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 124.851 3.701 . . . . 0.0 113.759 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.3 mt -99.22 59.22 1.13 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.597 0.759 . . . . 0.0 109.084 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 65.67 -113.83 6.12 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 124.031 0.824 . . . . 0.0 111.109 176.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 39.6 t-105 -96.46 93.76 7.0 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.447 1.099 . . . . 0.0 108.621 -177.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 64.5 t -99.68 132.53 44.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.157 0 C-N-CA 125.076 1.35 . . . . 0.0 109.691 -169.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.5 m -99.97 138.7 36.68 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.734 1.214 . . . . 0.0 109.454 169.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -81.2 64.84 6.1 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.508 1.123 . . . . 0.0 109.844 176.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.083 0 O-C-N 122.061 -0.399 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 57.7 p . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 111.528 0.195 . . . . 0.0 111.528 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 98.7 m -81.46 99.94 9.03 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.221 1.408 . . . . 0.0 110.652 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -139.73 165.66 26.68 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 126.072 1.749 . . . . 0.0 108.478 176.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -78.06 133.56 37.89 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 172.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -149.18 -163.61 11.08 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -51.69 -44.74 42.48 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 124.735 3.623 . . . . 0.0 113.779 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.5 mt -99.05 60.38 1.2 Allowed 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.545 0.738 . . . . 0.0 109.02 -176.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 62.01 -117.75 12.45 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -88.39 127.47 35.5 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 172.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 65.1 t -122.83 109.89 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 125.003 1.321 . . . . 0.0 108.761 -170.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 64.8 m -99.36 86.65 3.44 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.508 1.123 . . . . 0.0 108.731 173.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -79.82 76.52 6.5 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.43 1.092 . . . . 0.0 108.837 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.057 0 O-C-N 122.115 -0.365 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 44.0 m . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 111.287 0.106 . . . . 0.0 111.287 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 94.9 m -88.95 112.86 23.84 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.7 1.2 . . . . 0.0 109.201 174.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -148.84 163.92 35.99 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.421 1.088 . . . . 0.0 109.892 -175.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -73.88 94.8 2.35 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 174.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -103.57 -169.12 25.57 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.05 1.31 . . . . 0.0 110.612 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -64.17 -37.35 42.07 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 123.327 2.684 . . . . 0.0 111.693 -178.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 78.5 mt -99.43 54.7 0.96 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.725 0.81 . . . . 0.0 109.364 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.46 -125.92 18.18 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 174.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 49.5 t-105 -87.17 97.1 10.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 89.8 t -99.56 110.77 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 124.64 1.176 . . . . 0.0 109.042 -170.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 93.4 m -99.71 104.53 16.26 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.548 1.539 . . . . 0.0 109.672 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -79.69 72.68 6.39 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 171.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.054 0 O-C-N 122.162 -0.336 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 48.0 p . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 119.848 -0.12 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 84.0 m -141.86 129.63 21.68 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.294 1.438 . . . . 0.0 109.335 177.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.6 p-80 -120.66 142.99 48.95 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 124.586 1.154 . . . . 0.0 108.014 171.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -72.99 141.95 47.74 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.27 -163.43 15.03 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -176.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -51.93 -45.04 41.12 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 124.665 3.577 . . . . 0.0 113.592 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.8 mt -99.14 60.54 1.2 Allowed 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.659 0.784 . . . . 0.0 108.95 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.68 -128.71 48.3 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -80.66 116.39 20.65 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 170.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.8 t -99.14 105.15 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -178.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 60.1 m -102.93 159.24 15.68 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.569 1.148 . . . . 0.0 111.19 -175.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.5 166.77 31.65 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.225 1.01 . . . . 0.0 110.242 178.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.069 0 O-C-N 122.283 -0.261 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.474 0.73 0 CA-C-O 120.722 0.296 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 63.5 m -79.86 153.87 28.77 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.318 0.647 . . . . 0.0 110.183 -178.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.2 p-80 -102.03 150.05 23.63 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.197 0.999 . . . . 0.0 108.421 170.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -78.01 91.38 4.24 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -97.87 -165.96 31.7 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.065 1.317 . . . . 0.0 110.939 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -52.3 -45.31 40.29 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 124.643 3.562 . . . . 0.0 113.068 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 72.3 mt -99.4 52.44 0.94 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.854 0.862 . . . . 0.0 109.542 -177.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 65.67 -136.83 36.38 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 178.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -73.77 96.9 2.62 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.049 0.54 . . . . 0.0 110.436 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 83.9 t -99.71 123.86 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 125.323 1.449 . . . . 0.0 108.331 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.7 m -99.28 157.88 16.08 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.105 0.962 . . . . 0.0 109.236 172.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -83.22 71.03 10.21 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.736 1.214 . . . . 0.0 108.736 -175.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.049 0 O-C-N 122.207 -0.308 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 N--CA 1.473 0.702 0 CA-C-O 120.775 0.321 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 70.0 m -79.92 149.71 30.8 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.357 0.663 . . . . 0.0 110.393 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.5 p-80 -95.35 149.25 21.57 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 124.451 1.101 . . . . 0.0 108.268 169.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -73.33 136.46 44.47 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -156.77 -165.02 14.17 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -176.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -50.82 -47.78 23.75 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 124.808 3.672 . . . . 0.0 113.678 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.8 mt -99.19 61.45 1.23 Allowed 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.46 -118.74 15.81 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 178.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -89.67 104.58 17.13 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.882 0.873 . . . . 0.0 109.428 175.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 64.7 t -99.89 121.56 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 125.328 1.451 . . . . 0.0 108.812 -176.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.7 m -99.3 161.8 13.41 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.785 0.834 . . . . 0.0 109.007 171.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -150.09 163.69 37.52 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.688 1.195 . . . . 0.0 109.577 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.086 0 O-C-N 122.287 -0.258 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 120.368 0.127 . . . . 0.0 111.303 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 40.1 m -79.76 167.89 20.03 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.22 0.608 . . . . 0.0 110.914 -178.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 39.8 p-80 -157.04 172.17 19.15 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.922 1.289 . . . . 0.0 109.084 -169.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -91.09 135.48 33.73 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 171.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -152.91 -165.02 12.95 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -178.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -50.7 -45.92 32.82 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 124.893 3.729 . . . . 0.0 114.181 -176.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -98.94 65.93 1.53 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 59.58 -121.55 27.08 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 176.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -85.58 106.08 16.62 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 174.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.8 t -99.88 126.35 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 124.913 1.285 . . . . 0.0 108.832 -175.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.2 m -99.69 163.02 12.66 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.975 0.91 . . . . 0.0 110.595 176.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.19 167.51 25.79 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.775 1.23 . . . . 0.0 109.761 177.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.094 0 O-C-N 122.238 -0.289 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 111.272 0.101 . . . . 0.0 111.272 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 11.9 m -81.81 143.74 31.55 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.367 0.667 . . . . 0.0 111.705 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.4 p-80 -150.9 165.84 32.42 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.057 1.743 . . . . 0.0 108.235 -176.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -75.06 81.53 2.24 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.198 0.599 . . . . 0.0 109.798 177.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -89.88 -163.31 39.1 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.485 1.517 . . . . 0.0 110.754 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -66.53 -42.7 9.08 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.275 2.65 . . . . 0.0 111.625 -174.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 73.1 mt -99.51 49.47 0.94 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.796 0.838 . . . . 0.0 109.649 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 73.39 -128.72 11.71 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 176.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 36.9 t-105 -83.07 80.92 8.9 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.66 0.784 . . . . 0.0 109.995 -173.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.6 t -99.6 134.32 39.29 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 124.946 1.298 . . . . 0.0 109.453 -171.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.6 m -99.13 132.76 44.21 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.324 1.45 . . . . 0.0 109.894 177.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -138.24 163.43 31.77 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.491 1.516 . . . . 0.0 108.302 171.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.065 0 O-C-N 122.206 -0.309 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 78.1 p . . . . . 0 N--CA 1.474 0.75 0 CA-C-O 120.251 0.072 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.8 m -97.81 156.37 16.61 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 123.896 0.879 . . . . 0.0 112.207 -178.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.2 p-80 -159.63 162.01 35.12 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 127.101 2.16 . . . . 0.0 107.316 -170.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -73.85 123.44 24.22 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -135.61 -170.38 12.08 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.311 1.434 . . . . 0.0 110.198 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -65.5 -35.57 38.16 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.543 2.829 . . . . 0.0 112.34 -175.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -99.03 61.21 1.24 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 176.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 64.03 -115.29 7.73 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.163 0.887 . . . . 0.0 111.51 175.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 45.8 t-105 -98.24 93.84 6.45 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.416 1.086 . . . . 0.0 108.696 -177.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 96.4 t -99.69 136.89 28.99 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.124 0 C-N-CA 125.038 1.335 . . . . 0.0 109.487 -170.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.7 m -99.92 147.49 25.5 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.45 1.1 . . . . 0.0 110.615 171.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -79.78 75.82 6.46 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.321 1.048 . . . . 0.0 109.184 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.095 0 O-C-N 122.126 -0.359 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 65.6 p . . . . . 0 N--CA 1.474 0.74 0 N-CA-C 111.416 0.154 . . . . 0.0 111.416 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.6 m -140.6 155.91 46.43 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.555 0.742 . . . . 0.0 110.367 174.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 -160.41 160.82 32.69 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.644 1.578 . . . . 0.0 108.016 -173.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -77.67 137.75 38.69 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -156.98 -164.21 13.31 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -178.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -50.87 -45.78 34.11 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 124.848 3.699 . . . . 0.0 113.861 -176.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.6 mt -99.08 61.58 1.25 Allowed 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -176.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.35 -121.21 25.87 Favored Glycine 0 C--N 1.34 0.756 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 178.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 65.2 t-105 -86.48 108.99 18.77 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 174.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.6 t -99.48 115.82 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 125.069 1.347 . . . . 0.0 108.849 -173.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 43.2 m -99.5 88.26 3.82 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.319 1.047 . . . . 0.0 109.198 176.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -139.22 154.34 48.0 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.033 1.333 . . . . 0.0 108.437 174.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.082 0 O-C-N 122.144 -0.348 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 N--CA 1.472 0.656 0 N-CA-C 111.257 0.095 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 95.9 m -87.03 105.92 17.48 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.934 1.294 . . . . 0.0 109.582 176.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -145.51 164.18 32.41 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 125.965 1.706 . . . . 0.0 108.474 -178.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -79.65 134.54 36.44 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 171.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -150.31 -164.4 11.85 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -177.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -52.21 -44.24 47.57 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 124.699 3.599 . . . . 0.0 113.678 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.9 mt -99.1 60.2 1.19 Allowed 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.617 0.767 . . . . 0.0 108.977 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.71 -119.18 17.2 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 62.5 t-105 -88.32 130.62 35.08 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 172.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.9 t -124.91 107.36 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 125.306 1.443 . . . . 0.0 108.782 -170.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 63.3 m -99.2 83.18 2.82 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 124.818 1.247 . . . . 0.0 108.303 171.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -79.98 79.05 6.57 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.152 0.981 . . . . 0.0 108.616 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.091 0 O-C-N 122.237 -0.29 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.472 0.639 0 CA-C-O 119.93 -0.081 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 91.9 m -89.03 105.66 17.93 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.717 1.207 . . . . 0.0 109.266 175.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 -145.65 160.79 41.17 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 125.727 1.611 . . . . 0.0 108.368 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -76.75 135.0 38.99 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 173.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -152.81 -163.72 11.9 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -177.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -51.73 -44.48 44.27 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 124.774 3.649 . . . . 0.0 113.762 -176.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.7 mt -99.05 60.31 1.2 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -176.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.96 -118.26 14.44 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 63.1 t-105 -88.8 126.29 35.28 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 172.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.2 t -120.08 104.79 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 125.263 1.425 . . . . 0.0 109.055 -170.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 70.3 m -99.38 81.26 2.51 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 125.01 1.324 . . . . 0.0 108.086 171.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -141.58 147.22 37.32 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 124.524 1.13 . . . . 0.0 109.119 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.083 0 O-C-N 122.198 -0.314 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 94.8 p . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 111.439 0.162 . . . . 0.0 111.439 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 92.3 m -142.39 142.43 32.41 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 124.555 1.142 . . . . 0.0 109.048 173.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.1 p-80 -160.51 162.21 32.98 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.488 1.115 . . . . 0.0 109.764 -169.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -77.25 97.55 4.86 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 171.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.49 -167.28 29.88 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.044 1.307 . . . . 0.0 110.512 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -65.12 -37.21 33.53 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.246 2.631 . . . . 0.0 111.609 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.1 mt -99.4 54.32 0.96 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.761 0.824 . . . . 0.0 109.482 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.39 -133.12 23.54 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 175.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 61.8 t-105 -80.53 96.01 6.67 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.5 t -99.48 137.39 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 124.907 1.283 . . . . 0.0 108.543 -175.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 77.6 m -119.79 145.85 46.22 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.46 1.104 . . . . 0.0 109.962 176.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -141.34 150.58 42.66 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.153 1.381 . . . . 0.0 108.983 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.081 0 O-C-N 122.199 -0.313 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 46.0 m . . . . . 0 N--CA 1.475 0.782 0 CA-C-O 119.768 -0.158 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 74.0 m -140.69 147.87 39.91 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.19 0.996 . . . . 0.0 109.681 174.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.7 p-80 -160.41 162.5 33.3 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.695 1.198 . . . . 0.0 109.656 -169.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -77.12 97.1 4.63 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 172.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.63 -167.99 29.82 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.973 1.273 . . . . 0.0 110.539 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -64.93 -37.37 34.33 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.333 2.689 . . . . 0.0 111.602 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.2 mt -99.38 54.41 0.96 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.791 0.837 . . . . 0.0 109.486 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.39 -132.16 22.75 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 175.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -81.27 96.09 7.17 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 95.2 t -99.5 140.94 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 124.8 1.24 . . . . 0.0 108.542 -175.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 79.0 m -122.87 149.18 44.54 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.448 1.099 . . . . 0.0 110.414 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -142.97 148.11 36.3 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.485 1.514 . . . . 0.0 108.624 177.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 -0.013 0 O-C-N 122.214 -0.304 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 42.8 m . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 37.3 m -139.68 168.08 20.64 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.83 0.852 . . . . 0.0 110.176 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 27.9 p-80 -160.05 171.56 19.1 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.911 1.284 . . . . 0.0 109.263 -169.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -87.96 138.85 31.09 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 170.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -150.07 -168.25 15.04 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -65.84 -34.1 40.83 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.442 2.762 . . . . 0.0 112.369 -175.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -98.97 63.48 1.36 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 176.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.2 -128.08 43.63 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 176.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -84.34 105.98 15.59 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 175.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.1 t -99.96 131.83 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 124.651 1.18 . . . . 0.0 108.807 -176.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 47.0 m -99.43 146.35 26.43 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.273 0.629 . . . . 0.0 110.245 177.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -82.51 69.9 9.37 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.275 1.03 . . . . 0.0 109.688 -173.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.085 0 O-C-N 122.151 -0.343 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 42.3 m . . . . . 0 N--CA 1.474 0.732 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.7 m -138.26 145.76 41.71 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.847 0.859 . . . . 0.0 109.967 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.9 p-80 -121.9 144.94 48.56 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.773 1.629 . . . . 0.0 107.806 176.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -71.62 142.63 49.96 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.8 -163.7 16.09 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -176.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -51.98 -45.77 36.62 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 124.706 3.604 . . . . 0.0 113.546 -177.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 76.4 mt -99.19 61.28 1.22 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.673 0.789 . . . . 0.0 108.968 -176.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.97 -128.07 46.81 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -81.15 115.82 20.76 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 170.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 67.0 t -99.15 114.87 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 96.8 m -99.51 144.29 28.77 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.007 0.923 . . . . 0.0 111.044 -171.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -80.14 73.9 6.95 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.229 1.011 . . . . 0.0 109.32 -177.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.056 0 O-C-N 122.069 -0.394 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 . . . . . 0 N--CA 1.455 -0.204 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -93.93 137.2 33.4 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 169.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -149.21 -164.98 11.95 Favored Glycine 0 CA--C 1.531 1.031 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -177.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -52.28 -44.87 43.24 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 124.635 3.557 . . . . 0.0 113.637 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.9 mt -99.19 61.04 1.21 Allowed 'General case' 0 C--N 1.339 0.152 0 C-N-CA 123.605 0.762 . . . . 0.0 109.032 -175.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.69 -120.47 20.45 Favored Glycine 0 C--N 1.339 0.708 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 -84.83 127.76 34.29 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 172.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 66.9 t . . . . . 0 N--CA 1.456 -0.138 0 C-N-CA 124.91 1.284 . . . . 0.0 108.602 -174.777 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.7 p-80 . . . . . 0 N--CA 1.455 -0.185 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -80.76 140.79 35.33 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 172.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -151.24 -167.4 14.74 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -177.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.0 -34.07 39.52 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.408 2.739 . . . . 0.0 111.918 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.8 mt -99.1 60.46 1.2 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.4 -129.81 45.79 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 71.8 t-105 -85.2 109.92 18.65 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 68.6 t . . . . . 0 N--CA 1.455 -0.205 0 C-N-CA 124.764 1.225 . . . . 0.0 108.726 -175.418 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.3 p-80 . . . . . 0 CA--C 1.529 0.155 0 CA-C-O 120.734 0.302 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -85.4 122.51 29.66 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 171.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -139.81 -165.7 10.37 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.752 1.168 . . . . 0.0 110.716 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 99.5 Cg_exo -49.58 -48.26 19.7 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 124.865 3.71 . . . . 0.0 113.978 -176.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.2 mt -99.26 61.62 1.22 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.603 0.761 . . . . 0.0 109.075 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.36 -117.92 12.39 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 177.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 63.0 t-105 -87.36 97.53 10.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.2 t . . . . . 0 N--CA 1.455 -0.202 0 C-N-CA 125.096 1.359 . . . . 0.0 109.2 -174.795 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -73.77 92.91 2.06 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 173.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -92.92 -166.49 38.62 Favored Glycine 0 CA--C 1.532 1.109 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 173.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -63.63 -36.14 54.72 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.163 2.575 . . . . 0.0 111.829 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.8 mt -99.45 53.2 0.94 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.747 0.819 . . . . 0.0 109.579 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.83 -134.19 40.76 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -68.34 100.47 1.07 Allowed 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 117.37 0.585 . . . . 0.0 109.959 174.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 70.8 t . . . . . 0 N--CA 1.452 -0.349 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 173.924 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.7 p-80 . . . . . 0 N--CA 1.451 -0.382 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -71.99 128.68 36.49 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 176.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -149.64 -168.03 14.65 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.475 1.036 . . . . 0.0 110.543 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -50.4 -48.93 18.1 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 124.851 3.701 . . . . 0.0 113.759 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.3 mt -99.22 59.22 1.13 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.597 0.759 . . . . 0.0 109.084 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 65.67 -113.83 6.12 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 124.031 0.824 . . . . 0.0 111.109 176.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 39.6 t-105 -96.46 93.76 7.0 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.447 1.099 . . . . 0.0 108.621 -177.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 64.5 t . . . . . 0 C--O 1.226 -0.157 0 C-N-CA 125.076 1.35 . . . . 0.0 109.691 -169.87 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 . . . . . 0 CA--C 1.53 0.192 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -78.06 133.56 37.89 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 172.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -149.18 -163.61 11.08 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -51.69 -44.74 42.48 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 124.735 3.623 . . . . 0.0 113.779 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.5 mt -99.05 60.38 1.2 Allowed 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.545 0.738 . . . . 0.0 109.02 -176.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 62.01 -117.75 12.45 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -88.39 127.47 35.5 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 172.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 65.1 t . . . . . 0 N--CA 1.454 -0.272 0 C-N-CA 125.003 1.321 . . . . 0.0 108.761 -170.493 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 . . . . . 0 CA--C 1.528 0.129 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -73.88 94.8 2.35 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 174.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -103.57 -169.12 25.57 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.05 1.31 . . . . 0.0 110.612 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -64.17 -37.35 42.07 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 123.327 2.684 . . . . 0.0 111.693 -178.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 78.5 mt -99.43 54.7 0.96 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.725 0.81 . . . . 0.0 109.364 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.46 -125.92 18.18 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 174.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 49.5 t-105 -87.17 97.1 10.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 89.8 t . . . . . 0 N--CA 1.454 -0.226 0 C-N-CA 124.64 1.176 . . . . 0.0 109.042 -170.398 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.6 p-80 . . . . . 0 N--CA 1.458 -0.069 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -72.99 141.95 47.74 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.27 -163.43 15.03 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -176.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -51.93 -45.04 41.12 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 124.665 3.577 . . . . 0.0 113.592 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.8 mt -99.14 60.54 1.2 Allowed 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.659 0.784 . . . . 0.0 108.95 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.68 -128.71 48.3 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -80.66 116.39 20.65 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 170.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.8 t . . . . . 0 N--CA 1.451 -0.38 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -178.243 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.2 p-80 . . . . . 0 N--CA 1.456 -0.134 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -78.01 91.38 4.24 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -97.87 -165.96 31.7 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.065 1.317 . . . . 0.0 110.939 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -52.3 -45.31 40.29 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 124.643 3.562 . . . . 0.0 113.068 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 72.3 mt -99.4 52.44 0.94 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.854 0.862 . . . . 0.0 109.542 -177.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 65.67 -136.83 36.38 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 178.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -73.77 96.9 2.62 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.049 0.54 . . . . 0.0 110.436 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 83.9 t . . . . . 0 N--CA 1.454 -0.25 0 C-N-CA 125.323 1.449 . . . . 0.0 108.331 179.077 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.5 p-80 . . . . . 0 N--CA 1.456 -0.154 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -73.33 136.46 44.47 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -156.77 -165.02 14.17 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -176.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -50.82 -47.78 23.75 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 124.808 3.672 . . . . 0.0 113.678 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.8 mt -99.19 61.45 1.23 Allowed 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.46 -118.74 15.81 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 178.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -89.67 104.58 17.13 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.882 0.873 . . . . 0.0 109.428 175.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 64.7 t . . . . . 0 N--CA 1.453 -0.313 0 C-N-CA 125.328 1.451 . . . . 0.0 108.812 -176.166 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 39.8 p-80 . . . . . 0 N--CA 1.454 -0.244 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -91.09 135.48 33.73 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 171.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -152.91 -165.02 12.95 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -178.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -50.7 -45.92 32.82 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 124.893 3.729 . . . . 0.0 114.181 -176.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -98.94 65.93 1.53 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 59.58 -121.55 27.08 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 176.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -85.58 106.08 16.62 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 174.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.8 t . . . . . 0 N--CA 1.455 -0.187 0 C-N-CA 124.913 1.285 . . . . 0.0 108.832 -175.64 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.4 p-80 . . . . . 0 N--CA 1.452 -0.332 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -75.06 81.53 2.24 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.198 0.599 . . . . 0.0 109.798 177.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -89.88 -163.31 39.1 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.485 1.517 . . . . 0.0 110.754 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -66.53 -42.7 9.08 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.275 2.65 . . . . 0.0 111.625 -174.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 73.1 mt -99.51 49.47 0.94 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.796 0.838 . . . . 0.0 109.649 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 73.39 -128.72 11.71 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 176.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 36.9 t-105 -83.07 80.92 8.9 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.66 0.784 . . . . 0.0 109.995 -173.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.6 t . . . . . 0 C--N 1.339 0.15 0 C-N-CA 124.946 1.298 . . . . 0.0 109.453 -171.94 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.2 p-80 . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -73.85 123.44 24.22 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -135.61 -170.38 12.08 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.311 1.434 . . . . 0.0 110.198 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -65.5 -35.57 38.16 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.543 2.829 . . . . 0.0 112.34 -175.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -99.03 61.21 1.24 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 176.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 64.03 -115.29 7.73 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.163 0.887 . . . . 0.0 111.51 175.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 45.8 t-105 -98.24 93.84 6.45 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.416 1.086 . . . . 0.0 108.696 -177.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 96.4 t . . . . . 0 C--O 1.227 -0.124 0 C-N-CA 125.038 1.335 . . . . 0.0 109.487 -170.042 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -77.67 137.75 38.69 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -156.98 -164.21 13.31 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -178.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -50.87 -45.78 34.11 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 124.848 3.699 . . . . 0.0 113.861 -176.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.6 mt -99.08 61.58 1.25 Allowed 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -176.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.35 -121.21 25.87 Favored Glycine 0 C--N 1.34 0.756 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 178.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 65.2 t-105 -86.48 108.99 18.77 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 174.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.6 t . . . . . 0 N--CA 1.453 -0.295 0 C-N-CA 125.069 1.347 . . . . 0.0 108.849 -173.596 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 . . . . . 0 N--CA 1.457 -0.107 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -79.65 134.54 36.44 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 171.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -150.31 -164.4 11.85 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -177.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -52.21 -44.24 47.57 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 124.699 3.599 . . . . 0.0 113.678 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.9 mt -99.1 60.2 1.19 Allowed 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.617 0.767 . . . . 0.0 108.977 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.71 -119.18 17.2 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 62.5 t-105 -88.32 130.62 35.08 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 172.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.9 t . . . . . 0 N--CA 1.453 -0.292 0 C-N-CA 125.306 1.443 . . . . 0.0 108.782 -170.619 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 . . . . . 0 N--CA 1.456 -0.136 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -76.75 135.0 38.99 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 173.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -152.81 -163.72 11.9 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -177.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -51.73 -44.48 44.27 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 124.774 3.649 . . . . 0.0 113.762 -176.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.7 mt -99.05 60.31 1.2 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -176.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.96 -118.26 14.44 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 63.1 t-105 -88.8 126.29 35.28 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 172.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.2 t . . . . . 0 N--CA 1.454 -0.256 0 C-N-CA 125.263 1.425 . . . . 0.0 109.055 -170.005 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.1 p-80 . . . . . 0 N--CA 1.455 -0.219 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -77.25 97.55 4.86 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 171.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.49 -167.28 29.88 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.044 1.307 . . . . 0.0 110.512 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -65.12 -37.21 33.53 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.246 2.631 . . . . 0.0 111.609 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.1 mt -99.4 54.32 0.96 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.761 0.824 . . . . 0.0 109.482 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.39 -133.12 23.54 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 175.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 61.8 t-105 -80.53 96.01 6.67 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.5 t . . . . . 0 N--CA 1.456 -0.139 0 C-N-CA 124.907 1.283 . . . . 0.0 108.543 -175.922 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.7 p-80 . . . . . 0 N--CA 1.454 -0.238 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -77.12 97.1 4.63 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 172.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.63 -167.99 29.82 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.973 1.273 . . . . 0.0 110.539 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -64.93 -37.37 34.33 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.333 2.689 . . . . 0.0 111.602 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.2 mt -99.38 54.41 0.96 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.791 0.837 . . . . 0.0 109.486 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.39 -132.16 22.75 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 175.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -81.27 96.09 7.17 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 95.2 t . . . . . 0 N--CA 1.456 -0.157 0 C-N-CA 124.8 1.24 . . . . 0.0 108.542 -175.843 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 27.9 p-80 . . . . . 0 N--CA 1.454 -0.232 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -87.96 138.85 31.09 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 170.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -150.07 -168.25 15.04 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -65.84 -34.1 40.83 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.442 2.762 . . . . 0.0 112.369 -175.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -98.97 63.48 1.36 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 176.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.2 -128.08 43.63 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 176.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -84.34 105.98 15.59 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 175.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.1 t . . . . . 0 N--CA 1.455 -0.178 0 C-N-CA 124.651 1.18 . . . . 0.0 108.807 -176.319 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.9 p-80 . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -71.62 142.63 49.96 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.8 -163.7 16.09 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -176.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -51.98 -45.77 36.62 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 124.706 3.604 . . . . 0.0 113.546 -177.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 76.4 mt -99.19 61.28 1.22 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.673 0.789 . . . . 0.0 108.968 -176.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.97 -128.07 46.81 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -81.15 115.82 20.76 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 170.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 67.0 t . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -178.62 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.0 m . . . . . 0 N--CA 1.472 0.674 0 CA-C-O 119.654 -0.213 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 22.7 m -139.16 137.42 36.05 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.928 1.291 . . . . 0.0 108.406 174.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 -160.66 177.04 10.87 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.835 1.254 . . . . 0.0 109.366 -169.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -93.93 137.2 33.4 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 169.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -149.21 -164.98 11.95 Favored Glycine 0 CA--C 1.531 1.031 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -177.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -52.28 -44.87 43.24 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 124.635 3.557 . . . . 0.0 113.637 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.9 mt -99.19 61.04 1.21 Allowed 'General case' 0 C--N 1.339 0.152 0 C-N-CA 123.605 0.762 . . . . 0.0 109.032 -175.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.69 -120.47 20.45 Favored Glycine 0 C--N 1.339 0.708 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 -84.83 127.76 34.29 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 172.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 66.9 t -125.96 139.44 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 124.91 1.284 . . . . 0.0 108.602 -174.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 76.1 m -128.68 147.77 50.77 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.893 0.877 . . . . 0.0 109.232 175.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.0 mtpt -140.21 148.97 42.33 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.011 1.324 . . . . 0.0 108.884 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.077 0 O-C-N 122.335 -0.228 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 N--CA 1.474 0.727 0 N-CA-C 111.215 0.08 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.9 m -142.03 164.75 29.33 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.983 0.913 . . . . 0.0 110.01 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.7 p-80 -158.54 167.43 29.62 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.111 1.364 . . . . 0.0 108.935 -175.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -80.76 140.79 35.33 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 172.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -151.24 -167.4 14.74 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -177.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.0 -34.07 39.52 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.408 2.739 . . . . 0.0 111.918 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.8 mt -99.1 60.46 1.2 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.4 -129.81 45.79 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 71.8 t-105 -85.2 109.92 18.65 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 68.6 t -99.81 125.89 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 124.764 1.225 . . . . 0.0 108.726 -175.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 39.9 m -99.76 133.15 44.53 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.488 0.715 . . . . 0.0 109.968 175.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -88.46 66.55 8.31 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.811 1.244 . . . . 0.0 109.232 -172.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.065 0 CA-C-N 116.45 -0.341 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 N--CA 1.474 0.773 0 N-CA-C 111.828 0.306 . . . . 0.0 111.828 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 61.9 m -83.54 -175.82 6.0 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.97 0.908 . . . . 0.0 109.687 173.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.3 p-80 -147.49 168.92 20.7 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.621 0.769 . . . . 0.0 110.986 -169.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -85.4 122.51 29.66 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 171.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -139.81 -165.7 10.37 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.752 1.168 . . . . 0.0 110.716 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 99.5 Cg_exo -49.58 -48.26 19.7 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 124.865 3.71 . . . . 0.0 113.978 -176.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.2 mt -99.26 61.62 1.22 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.603 0.761 . . . . 0.0 109.075 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.36 -117.92 12.39 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 177.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 63.0 t-105 -87.36 97.53 10.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.2 t -99.77 132.69 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 125.096 1.359 . . . . 0.0 109.2 -174.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 96.6 m -99.66 144.03 29.21 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.058 0.943 . . . . 0.0 109.436 175.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.44 161.3 26.2 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.837 0.855 . . . . 0.0 110.886 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.063 0 O-C-N 122.21 -0.307 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.3 p . . . . . 0 N--CA 1.474 0.729 0 CA-C-O 120.347 0.118 . . . . 0.0 111.043 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 11.8 m -138.29 163.53 31.55 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.911 0.884 . . . . 0.0 110.156 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 -152.51 157.89 41.76 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.733 1.213 . . . . 0.0 109.303 -173.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -73.77 92.91 2.06 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 173.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -92.92 -166.49 38.62 Favored Glycine 0 CA--C 1.532 1.109 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 173.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -63.63 -36.14 54.72 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.163 2.575 . . . . 0.0 111.829 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.8 mt -99.45 53.2 0.94 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.747 0.819 . . . . 0.0 109.579 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.83 -134.19 40.76 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -68.34 100.47 1.07 Allowed 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 117.37 0.585 . . . . 0.0 109.959 174.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 70.8 t -99.46 125.44 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 173.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 95.0 m -99.83 139.34 35.63 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.967 0.907 . . . . 0.0 110.596 -177.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -155.72 91.11 1.27 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.075 0 O-C-N 122.186 -0.321 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.7 t . . . . . 0 N--CA 1.474 0.734 0 N-CA-C 111.347 0.129 . . . . 0.0 111.347 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.3 m -87.72 156.85 19.24 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.456 0.646 . . . . 0.0 110.414 169.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.7 p-80 -160.05 160.09 32.75 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.915 2.086 . . . . 0.0 107.125 -172.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -71.99 128.68 36.49 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 176.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -149.64 -168.03 14.65 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.475 1.036 . . . . 0.0 110.543 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -50.4 -48.93 18.1 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 124.851 3.701 . . . . 0.0 113.759 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.3 mt -99.22 59.22 1.13 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.597 0.759 . . . . 0.0 109.084 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 65.67 -113.83 6.12 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 124.031 0.824 . . . . 0.0 111.109 176.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 39.6 t-105 -96.46 93.76 7.0 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.447 1.099 . . . . 0.0 108.621 -177.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 64.5 t -99.68 132.53 44.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.157 0 C-N-CA 125.076 1.35 . . . . 0.0 109.691 -169.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.5 m -99.97 138.7 36.68 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.734 1.214 . . . . 0.0 109.454 169.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -81.2 64.84 6.1 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.508 1.123 . . . . 0.0 109.844 176.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.083 0 O-C-N 122.061 -0.399 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 57.7 p . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 111.528 0.195 . . . . 0.0 111.528 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 98.7 m -81.46 99.94 9.03 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.221 1.408 . . . . 0.0 110.652 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -139.73 165.66 26.68 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 126.072 1.749 . . . . 0.0 108.478 176.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -78.06 133.56 37.89 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 172.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -149.18 -163.61 11.08 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -51.69 -44.74 42.48 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 124.735 3.623 . . . . 0.0 113.779 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.5 mt -99.05 60.38 1.2 Allowed 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.545 0.738 . . . . 0.0 109.02 -176.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 62.01 -117.75 12.45 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -88.39 127.47 35.5 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 172.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 65.1 t -122.83 109.89 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 125.003 1.321 . . . . 0.0 108.761 -170.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 64.8 m -99.36 86.65 3.44 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.508 1.123 . . . . 0.0 108.731 173.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -79.82 76.52 6.5 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.43 1.092 . . . . 0.0 108.837 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.057 0 O-C-N 122.115 -0.365 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 44.0 m . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 111.287 0.106 . . . . 0.0 111.287 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 94.9 m -88.95 112.86 23.84 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.7 1.2 . . . . 0.0 109.201 174.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -148.84 163.92 35.99 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.421 1.088 . . . . 0.0 109.892 -175.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -73.88 94.8 2.35 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 174.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -103.57 -169.12 25.57 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.05 1.31 . . . . 0.0 110.612 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -64.17 -37.35 42.07 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 123.327 2.684 . . . . 0.0 111.693 -178.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 78.5 mt -99.43 54.7 0.96 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.725 0.81 . . . . 0.0 109.364 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.46 -125.92 18.18 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 174.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 49.5 t-105 -87.17 97.1 10.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 89.8 t -99.56 110.77 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 124.64 1.176 . . . . 0.0 109.042 -170.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 93.4 m -99.71 104.53 16.26 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.548 1.539 . . . . 0.0 109.672 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -79.69 72.68 6.39 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 171.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.054 0 O-C-N 122.162 -0.336 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 48.0 p . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 119.848 -0.12 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 84.0 m -141.86 129.63 21.68 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.294 1.438 . . . . 0.0 109.335 177.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.6 p-80 -120.66 142.99 48.95 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 124.586 1.154 . . . . 0.0 108.014 171.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -72.99 141.95 47.74 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.27 -163.43 15.03 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -176.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -51.93 -45.04 41.12 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 124.665 3.577 . . . . 0.0 113.592 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.8 mt -99.14 60.54 1.2 Allowed 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.659 0.784 . . . . 0.0 108.95 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.68 -128.71 48.3 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -80.66 116.39 20.65 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 170.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.8 t -99.14 105.15 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -178.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 60.1 m -102.93 159.24 15.68 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.569 1.148 . . . . 0.0 111.19 -175.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.5 166.77 31.65 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.225 1.01 . . . . 0.0 110.242 178.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.069 0 O-C-N 122.283 -0.261 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.474 0.73 0 CA-C-O 120.722 0.296 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 63.5 m -79.86 153.87 28.77 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.318 0.647 . . . . 0.0 110.183 -178.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.2 p-80 -102.03 150.05 23.63 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.197 0.999 . . . . 0.0 108.421 170.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -78.01 91.38 4.24 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -97.87 -165.96 31.7 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.065 1.317 . . . . 0.0 110.939 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -52.3 -45.31 40.29 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 124.643 3.562 . . . . 0.0 113.068 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 72.3 mt -99.4 52.44 0.94 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.854 0.862 . . . . 0.0 109.542 -177.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 65.67 -136.83 36.38 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 178.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -73.77 96.9 2.62 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.049 0.54 . . . . 0.0 110.436 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 83.9 t -99.71 123.86 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 125.323 1.449 . . . . 0.0 108.331 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.7 m -99.28 157.88 16.08 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.105 0.962 . . . . 0.0 109.236 172.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -83.22 71.03 10.21 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.736 1.214 . . . . 0.0 108.736 -175.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.049 0 O-C-N 122.207 -0.308 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 N--CA 1.473 0.702 0 CA-C-O 120.775 0.321 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 70.0 m -79.92 149.71 30.8 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.357 0.663 . . . . 0.0 110.393 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.5 p-80 -95.35 149.25 21.57 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 124.451 1.101 . . . . 0.0 108.268 169.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -73.33 136.46 44.47 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -156.77 -165.02 14.17 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -176.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -50.82 -47.78 23.75 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 124.808 3.672 . . . . 0.0 113.678 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.8 mt -99.19 61.45 1.23 Allowed 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.46 -118.74 15.81 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 178.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -89.67 104.58 17.13 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.882 0.873 . . . . 0.0 109.428 175.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 64.7 t -99.89 121.56 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 125.328 1.451 . . . . 0.0 108.812 -176.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.7 m -99.3 161.8 13.41 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.785 0.834 . . . . 0.0 109.007 171.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -150.09 163.69 37.52 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.688 1.195 . . . . 0.0 109.577 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.086 0 O-C-N 122.287 -0.258 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 120.368 0.127 . . . . 0.0 111.303 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 40.1 m -79.76 167.89 20.03 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.22 0.608 . . . . 0.0 110.914 -178.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 39.8 p-80 -157.04 172.17 19.15 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.922 1.289 . . . . 0.0 109.084 -169.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -91.09 135.48 33.73 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 171.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -152.91 -165.02 12.95 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -178.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -50.7 -45.92 32.82 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 124.893 3.729 . . . . 0.0 114.181 -176.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -98.94 65.93 1.53 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 59.58 -121.55 27.08 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 176.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -85.58 106.08 16.62 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 174.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.8 t -99.88 126.35 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 124.913 1.285 . . . . 0.0 108.832 -175.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.2 m -99.69 163.02 12.66 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.975 0.91 . . . . 0.0 110.595 176.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.19 167.51 25.79 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.775 1.23 . . . . 0.0 109.761 177.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.094 0 O-C-N 122.238 -0.289 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 111.272 0.101 . . . . 0.0 111.272 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 11.9 m -81.81 143.74 31.55 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.367 0.667 . . . . 0.0 111.705 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.4 p-80 -150.9 165.84 32.42 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.057 1.743 . . . . 0.0 108.235 -176.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -75.06 81.53 2.24 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.198 0.599 . . . . 0.0 109.798 177.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -89.88 -163.31 39.1 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.485 1.517 . . . . 0.0 110.754 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -66.53 -42.7 9.08 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.275 2.65 . . . . 0.0 111.625 -174.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 73.1 mt -99.51 49.47 0.94 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.796 0.838 . . . . 0.0 109.649 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 73.39 -128.72 11.71 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 176.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 36.9 t-105 -83.07 80.92 8.9 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.66 0.784 . . . . 0.0 109.995 -173.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.6 t -99.6 134.32 39.29 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 124.946 1.298 . . . . 0.0 109.453 -171.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.6 m -99.13 132.76 44.21 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.324 1.45 . . . . 0.0 109.894 177.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -138.24 163.43 31.77 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.491 1.516 . . . . 0.0 108.302 171.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.065 0 O-C-N 122.206 -0.309 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 78.1 p . . . . . 0 N--CA 1.474 0.75 0 CA-C-O 120.251 0.072 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.8 m -97.81 156.37 16.61 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 123.896 0.879 . . . . 0.0 112.207 -178.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.2 p-80 -159.63 162.01 35.12 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 127.101 2.16 . . . . 0.0 107.316 -170.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -73.85 123.44 24.22 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -135.61 -170.38 12.08 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.311 1.434 . . . . 0.0 110.198 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -65.5 -35.57 38.16 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.543 2.829 . . . . 0.0 112.34 -175.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -99.03 61.21 1.24 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 176.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 64.03 -115.29 7.73 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.163 0.887 . . . . 0.0 111.51 175.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 45.8 t-105 -98.24 93.84 6.45 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.416 1.086 . . . . 0.0 108.696 -177.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 96.4 t -99.69 136.89 28.99 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.124 0 C-N-CA 125.038 1.335 . . . . 0.0 109.487 -170.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.7 m -99.92 147.49 25.5 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.45 1.1 . . . . 0.0 110.615 171.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -79.78 75.82 6.46 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.321 1.048 . . . . 0.0 109.184 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.095 0 O-C-N 122.126 -0.359 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 65.6 p . . . . . 0 N--CA 1.474 0.74 0 N-CA-C 111.416 0.154 . . . . 0.0 111.416 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.6 m -140.6 155.91 46.43 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.555 0.742 . . . . 0.0 110.367 174.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 -160.41 160.82 32.69 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.644 1.578 . . . . 0.0 108.016 -173.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -77.67 137.75 38.69 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -156.98 -164.21 13.31 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -178.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -50.87 -45.78 34.11 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 124.848 3.699 . . . . 0.0 113.861 -176.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.6 mt -99.08 61.58 1.25 Allowed 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -176.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.35 -121.21 25.87 Favored Glycine 0 C--N 1.34 0.756 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 178.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 65.2 t-105 -86.48 108.99 18.77 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 174.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.6 t -99.48 115.82 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 125.069 1.347 . . . . 0.0 108.849 -173.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 43.2 m -99.5 88.26 3.82 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.319 1.047 . . . . 0.0 109.198 176.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -139.22 154.34 48.0 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.033 1.333 . . . . 0.0 108.437 174.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.082 0 O-C-N 122.144 -0.348 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 N--CA 1.472 0.656 0 N-CA-C 111.257 0.095 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 95.9 m -87.03 105.92 17.48 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.934 1.294 . . . . 0.0 109.582 176.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -145.51 164.18 32.41 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 125.965 1.706 . . . . 0.0 108.474 -178.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -79.65 134.54 36.44 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 171.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -150.31 -164.4 11.85 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -177.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -52.21 -44.24 47.57 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 124.699 3.599 . . . . 0.0 113.678 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.9 mt -99.1 60.2 1.19 Allowed 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.617 0.767 . . . . 0.0 108.977 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.71 -119.18 17.2 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 62.5 t-105 -88.32 130.62 35.08 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 172.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.9 t -124.91 107.36 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 125.306 1.443 . . . . 0.0 108.782 -170.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 63.3 m -99.2 83.18 2.82 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 124.818 1.247 . . . . 0.0 108.303 171.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -79.98 79.05 6.57 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.152 0.981 . . . . 0.0 108.616 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.091 0 O-C-N 122.237 -0.29 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.472 0.639 0 CA-C-O 119.93 -0.081 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 91.9 m -89.03 105.66 17.93 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.717 1.207 . . . . 0.0 109.266 175.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 -145.65 160.79 41.17 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 125.727 1.611 . . . . 0.0 108.368 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -76.75 135.0 38.99 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 173.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -152.81 -163.72 11.9 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -177.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -51.73 -44.48 44.27 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 124.774 3.649 . . . . 0.0 113.762 -176.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.7 mt -99.05 60.31 1.2 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -176.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.96 -118.26 14.44 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 63.1 t-105 -88.8 126.29 35.28 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 172.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.2 t -120.08 104.79 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 125.263 1.425 . . . . 0.0 109.055 -170.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 70.3 m -99.38 81.26 2.51 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 125.01 1.324 . . . . 0.0 108.086 171.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -141.58 147.22 37.32 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 124.524 1.13 . . . . 0.0 109.119 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.083 0 O-C-N 122.198 -0.314 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 94.8 p . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 111.439 0.162 . . . . 0.0 111.439 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 92.3 m -142.39 142.43 32.41 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 124.555 1.142 . . . . 0.0 109.048 173.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.1 p-80 -160.51 162.21 32.98 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.488 1.115 . . . . 0.0 109.764 -169.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -77.25 97.55 4.86 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 171.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.49 -167.28 29.88 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.044 1.307 . . . . 0.0 110.512 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -65.12 -37.21 33.53 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.246 2.631 . . . . 0.0 111.609 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.1 mt -99.4 54.32 0.96 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.761 0.824 . . . . 0.0 109.482 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.39 -133.12 23.54 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 175.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 61.8 t-105 -80.53 96.01 6.67 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.5 t -99.48 137.39 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 124.907 1.283 . . . . 0.0 108.543 -175.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 77.6 m -119.79 145.85 46.22 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.46 1.104 . . . . 0.0 109.962 176.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -141.34 150.58 42.66 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.153 1.381 . . . . 0.0 108.983 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.081 0 O-C-N 122.199 -0.313 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 46.0 m . . . . . 0 N--CA 1.475 0.782 0 CA-C-O 119.768 -0.158 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 74.0 m -140.69 147.87 39.91 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.19 0.996 . . . . 0.0 109.681 174.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.7 p-80 -160.41 162.5 33.3 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.695 1.198 . . . . 0.0 109.656 -169.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -77.12 97.1 4.63 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 172.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.63 -167.99 29.82 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.973 1.273 . . . . 0.0 110.539 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -64.93 -37.37 34.33 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.333 2.689 . . . . 0.0 111.602 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.2 mt -99.38 54.41 0.96 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.791 0.837 . . . . 0.0 109.486 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.39 -132.16 22.75 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 175.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -81.27 96.09 7.17 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 95.2 t -99.5 140.94 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 124.8 1.24 . . . . 0.0 108.542 -175.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 79.0 m -122.87 149.18 44.54 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.448 1.099 . . . . 0.0 110.414 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -142.97 148.11 36.3 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.485 1.514 . . . . 0.0 108.624 177.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 -0.013 0 O-C-N 122.214 -0.304 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 42.8 m . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 37.3 m -139.68 168.08 20.64 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.83 0.852 . . . . 0.0 110.176 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 27.9 p-80 -160.05 171.56 19.1 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.911 1.284 . . . . 0.0 109.263 -169.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -87.96 138.85 31.09 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 170.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -150.07 -168.25 15.04 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -65.84 -34.1 40.83 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.442 2.762 . . . . 0.0 112.369 -175.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -98.97 63.48 1.36 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 176.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.2 -128.08 43.63 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 176.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -84.34 105.98 15.59 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 175.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.1 t -99.96 131.83 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 124.651 1.18 . . . . 0.0 108.807 -176.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 47.0 m -99.43 146.35 26.43 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.273 0.629 . . . . 0.0 110.245 177.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -82.51 69.9 9.37 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.275 1.03 . . . . 0.0 109.688 -173.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.085 0 O-C-N 122.151 -0.343 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 42.3 m . . . . . 0 N--CA 1.474 0.732 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.7 m -138.26 145.76 41.71 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.847 0.859 . . . . 0.0 109.967 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.9 p-80 -121.9 144.94 48.56 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.773 1.629 . . . . 0.0 107.806 176.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -71.62 142.63 49.96 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.8 -163.7 16.09 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -176.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -51.98 -45.77 36.62 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 124.706 3.604 . . . . 0.0 113.546 -177.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 76.4 mt -99.19 61.28 1.22 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.673 0.789 . . . . 0.0 108.968 -176.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.97 -128.07 46.81 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -81.15 115.82 20.76 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 170.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 67.0 t -99.15 114.87 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 96.8 m -99.51 144.29 28.77 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.007 0.923 . . . . 0.0 111.044 -171.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -80.14 73.9 6.95 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.229 1.011 . . . . 0.0 109.32 -177.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.056 0 O-C-N 122.069 -0.394 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 . . . . . 0 N--CA 1.455 -0.204 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -93.93 137.2 33.4 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 169.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -149.21 -164.98 11.95 Favored Glycine 0 CA--C 1.531 1.031 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -177.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -52.28 -44.87 43.24 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 124.635 3.557 . . . . 0.0 113.637 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.9 mt -99.19 61.04 1.21 Allowed 'General case' 0 C--N 1.339 0.152 0 C-N-CA 123.605 0.762 . . . . 0.0 109.032 -175.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.69 -120.47 20.45 Favored Glycine 0 C--N 1.339 0.708 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 -84.83 127.76 34.29 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 172.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 66.9 t . . . . . 0 N--CA 1.456 -0.138 0 C-N-CA 124.91 1.284 . . . . 0.0 108.602 -174.777 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.7 p-80 . . . . . 0 N--CA 1.455 -0.185 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -80.76 140.79 35.33 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 172.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -151.24 -167.4 14.74 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -177.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.0 -34.07 39.52 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.408 2.739 . . . . 0.0 111.918 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.8 mt -99.1 60.46 1.2 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.4 -129.81 45.79 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 71.8 t-105 -85.2 109.92 18.65 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 68.6 t . . . . . 0 N--CA 1.455 -0.205 0 C-N-CA 124.764 1.225 . . . . 0.0 108.726 -175.418 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.3 p-80 . . . . . 0 CA--C 1.529 0.155 0 CA-C-O 120.734 0.302 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -85.4 122.51 29.66 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 171.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -139.81 -165.7 10.37 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.752 1.168 . . . . 0.0 110.716 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 99.5 Cg_exo -49.58 -48.26 19.7 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 124.865 3.71 . . . . 0.0 113.978 -176.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.2 mt -99.26 61.62 1.22 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.603 0.761 . . . . 0.0 109.075 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.36 -117.92 12.39 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 177.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 63.0 t-105 -87.36 97.53 10.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.2 t . . . . . 0 N--CA 1.455 -0.202 0 C-N-CA 125.096 1.359 . . . . 0.0 109.2 -174.795 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -73.77 92.91 2.06 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 173.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -92.92 -166.49 38.62 Favored Glycine 0 CA--C 1.532 1.109 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 173.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -63.63 -36.14 54.72 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.163 2.575 . . . . 0.0 111.829 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.8 mt -99.45 53.2 0.94 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.747 0.819 . . . . 0.0 109.579 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.83 -134.19 40.76 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -68.34 100.47 1.07 Allowed 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 117.37 0.585 . . . . 0.0 109.959 174.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 70.8 t . . . . . 0 N--CA 1.452 -0.349 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 173.924 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.7 p-80 . . . . . 0 N--CA 1.451 -0.382 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -71.99 128.68 36.49 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 176.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -149.64 -168.03 14.65 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.475 1.036 . . . . 0.0 110.543 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -50.4 -48.93 18.1 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 124.851 3.701 . . . . 0.0 113.759 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.3 mt -99.22 59.22 1.13 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.597 0.759 . . . . 0.0 109.084 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 65.67 -113.83 6.12 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 124.031 0.824 . . . . 0.0 111.109 176.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 39.6 t-105 -96.46 93.76 7.0 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.447 1.099 . . . . 0.0 108.621 -177.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 64.5 t . . . . . 0 C--O 1.226 -0.157 0 C-N-CA 125.076 1.35 . . . . 0.0 109.691 -169.87 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 . . . . . 0 CA--C 1.53 0.192 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -78.06 133.56 37.89 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 172.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -149.18 -163.61 11.08 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -51.69 -44.74 42.48 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 124.735 3.623 . . . . 0.0 113.779 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.5 mt -99.05 60.38 1.2 Allowed 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.545 0.738 . . . . 0.0 109.02 -176.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 62.01 -117.75 12.45 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -88.39 127.47 35.5 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 172.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 65.1 t . . . . . 0 N--CA 1.454 -0.272 0 C-N-CA 125.003 1.321 . . . . 0.0 108.761 -170.493 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 . . . . . 0 CA--C 1.528 0.129 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -73.88 94.8 2.35 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 174.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -103.57 -169.12 25.57 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.05 1.31 . . . . 0.0 110.612 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -64.17 -37.35 42.07 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 123.327 2.684 . . . . 0.0 111.693 -178.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 78.5 mt -99.43 54.7 0.96 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.725 0.81 . . . . 0.0 109.364 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.46 -125.92 18.18 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 174.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 49.5 t-105 -87.17 97.1 10.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 89.8 t . . . . . 0 N--CA 1.454 -0.226 0 C-N-CA 124.64 1.176 . . . . 0.0 109.042 -170.398 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.6 p-80 . . . . . 0 N--CA 1.458 -0.069 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -72.99 141.95 47.74 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.27 -163.43 15.03 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -176.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -51.93 -45.04 41.12 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 124.665 3.577 . . . . 0.0 113.592 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.8 mt -99.14 60.54 1.2 Allowed 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.659 0.784 . . . . 0.0 108.95 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.68 -128.71 48.3 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -80.66 116.39 20.65 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 170.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.8 t . . . . . 0 N--CA 1.451 -0.38 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -178.243 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.2 p-80 . . . . . 0 N--CA 1.456 -0.134 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -78.01 91.38 4.24 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -97.87 -165.96 31.7 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.065 1.317 . . . . 0.0 110.939 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -52.3 -45.31 40.29 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 124.643 3.562 . . . . 0.0 113.068 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 72.3 mt -99.4 52.44 0.94 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.854 0.862 . . . . 0.0 109.542 -177.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 65.67 -136.83 36.38 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 178.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -73.77 96.9 2.62 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.049 0.54 . . . . 0.0 110.436 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 83.9 t . . . . . 0 N--CA 1.454 -0.25 0 C-N-CA 125.323 1.449 . . . . 0.0 108.331 179.077 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.5 p-80 . . . . . 0 N--CA 1.456 -0.154 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -73.33 136.46 44.47 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -156.77 -165.02 14.17 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -176.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -50.82 -47.78 23.75 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 124.808 3.672 . . . . 0.0 113.678 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.8 mt -99.19 61.45 1.23 Allowed 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.46 -118.74 15.81 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 178.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -89.67 104.58 17.13 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.882 0.873 . . . . 0.0 109.428 175.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 64.7 t . . . . . 0 N--CA 1.453 -0.313 0 C-N-CA 125.328 1.451 . . . . 0.0 108.812 -176.166 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 39.8 p-80 . . . . . 0 N--CA 1.454 -0.244 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -91.09 135.48 33.73 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 171.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -152.91 -165.02 12.95 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -178.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -50.7 -45.92 32.82 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 124.893 3.729 . . . . 0.0 114.181 -176.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -98.94 65.93 1.53 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 59.58 -121.55 27.08 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 176.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -85.58 106.08 16.62 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 174.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.8 t . . . . . 0 N--CA 1.455 -0.187 0 C-N-CA 124.913 1.285 . . . . 0.0 108.832 -175.64 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.4 p-80 . . . . . 0 N--CA 1.452 -0.332 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -75.06 81.53 2.24 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.198 0.599 . . . . 0.0 109.798 177.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -89.88 -163.31 39.1 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.485 1.517 . . . . 0.0 110.754 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -66.53 -42.7 9.08 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.275 2.65 . . . . 0.0 111.625 -174.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 73.1 mt -99.51 49.47 0.94 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.796 0.838 . . . . 0.0 109.649 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 73.39 -128.72 11.71 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 176.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 36.9 t-105 -83.07 80.92 8.9 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.66 0.784 . . . . 0.0 109.995 -173.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.6 t . . . . . 0 C--N 1.339 0.15 0 C-N-CA 124.946 1.298 . . . . 0.0 109.453 -171.94 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.2 p-80 . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -73.85 123.44 24.22 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -135.61 -170.38 12.08 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.311 1.434 . . . . 0.0 110.198 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -65.5 -35.57 38.16 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.543 2.829 . . . . 0.0 112.34 -175.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -99.03 61.21 1.24 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 176.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 64.03 -115.29 7.73 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.163 0.887 . . . . 0.0 111.51 175.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 45.8 t-105 -98.24 93.84 6.45 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.416 1.086 . . . . 0.0 108.696 -177.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 96.4 t . . . . . 0 C--O 1.227 -0.124 0 C-N-CA 125.038 1.335 . . . . 0.0 109.487 -170.042 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -77.67 137.75 38.69 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -156.98 -164.21 13.31 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -178.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -50.87 -45.78 34.11 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 124.848 3.699 . . . . 0.0 113.861 -176.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.6 mt -99.08 61.58 1.25 Allowed 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -176.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.35 -121.21 25.87 Favored Glycine 0 C--N 1.34 0.756 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 178.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 65.2 t-105 -86.48 108.99 18.77 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 174.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.6 t . . . . . 0 N--CA 1.453 -0.295 0 C-N-CA 125.069 1.347 . . . . 0.0 108.849 -173.596 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 . . . . . 0 N--CA 1.457 -0.107 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -79.65 134.54 36.44 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 171.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -150.31 -164.4 11.85 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -177.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -52.21 -44.24 47.57 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 124.699 3.599 . . . . 0.0 113.678 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.9 mt -99.1 60.2 1.19 Allowed 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.617 0.767 . . . . 0.0 108.977 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.71 -119.18 17.2 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 62.5 t-105 -88.32 130.62 35.08 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 172.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.9 t . . . . . 0 N--CA 1.453 -0.292 0 C-N-CA 125.306 1.443 . . . . 0.0 108.782 -170.619 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 . . . . . 0 N--CA 1.456 -0.136 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -76.75 135.0 38.99 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 173.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -152.81 -163.72 11.9 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -177.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -51.73 -44.48 44.27 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 124.774 3.649 . . . . 0.0 113.762 -176.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.7 mt -99.05 60.31 1.2 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -176.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.96 -118.26 14.44 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 63.1 t-105 -88.8 126.29 35.28 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 172.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.2 t . . . . . 0 N--CA 1.454 -0.256 0 C-N-CA 125.263 1.425 . . . . 0.0 109.055 -170.005 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.1 p-80 . . . . . 0 N--CA 1.455 -0.219 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -77.25 97.55 4.86 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 171.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.49 -167.28 29.88 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.044 1.307 . . . . 0.0 110.512 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -65.12 -37.21 33.53 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.246 2.631 . . . . 0.0 111.609 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.1 mt -99.4 54.32 0.96 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.761 0.824 . . . . 0.0 109.482 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.39 -133.12 23.54 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 175.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 61.8 t-105 -80.53 96.01 6.67 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.5 t . . . . . 0 N--CA 1.456 -0.139 0 C-N-CA 124.907 1.283 . . . . 0.0 108.543 -175.922 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.7 p-80 . . . . . 0 N--CA 1.454 -0.238 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -77.12 97.1 4.63 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 172.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.63 -167.99 29.82 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.973 1.273 . . . . 0.0 110.539 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -64.93 -37.37 34.33 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.333 2.689 . . . . 0.0 111.602 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.2 mt -99.38 54.41 0.96 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.791 0.837 . . . . 0.0 109.486 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.39 -132.16 22.75 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 175.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -81.27 96.09 7.17 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 95.2 t . . . . . 0 N--CA 1.456 -0.157 0 C-N-CA 124.8 1.24 . . . . 0.0 108.542 -175.843 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 27.9 p-80 . . . . . 0 N--CA 1.454 -0.232 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -87.96 138.85 31.09 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 170.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -150.07 -168.25 15.04 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -65.84 -34.1 40.83 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.442 2.762 . . . . 0.0 112.369 -175.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -98.97 63.48 1.36 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 176.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.2 -128.08 43.63 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 176.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -84.34 105.98 15.59 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 175.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.1 t . . . . . 0 N--CA 1.455 -0.178 0 C-N-CA 124.651 1.18 . . . . 0.0 108.807 -176.319 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.9 p-80 . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -71.62 142.63 49.96 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.8 -163.7 16.09 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -176.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -51.98 -45.77 36.62 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 124.706 3.604 . . . . 0.0 113.546 -177.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 76.4 mt -99.19 61.28 1.22 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.673 0.789 . . . . 0.0 108.968 -176.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.97 -128.07 46.81 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -81.15 115.82 20.76 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 170.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 67.0 t . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -178.62 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.0 m . . . . . 0 N--CA 1.472 0.674 0 CA-C-O 119.654 -0.213 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 22.7 m -139.16 137.42 36.05 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.928 1.291 . . . . 0.0 108.406 174.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 -160.66 177.04 10.87 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.835 1.254 . . . . 0.0 109.366 -169.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -93.93 137.2 33.4 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 169.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -149.21 -164.98 11.95 Favored Glycine 0 CA--C 1.531 1.031 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -177.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -52.28 -44.87 43.24 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 124.635 3.557 . . . . 0.0 113.637 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.9 mt -99.19 61.04 1.21 Allowed 'General case' 0 C--N 1.339 0.152 0 C-N-CA 123.605 0.762 . . . . 0.0 109.032 -175.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.69 -120.47 20.45 Favored Glycine 0 C--N 1.339 0.708 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 -84.83 127.76 34.29 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 172.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 66.9 t -125.96 139.44 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 124.91 1.284 . . . . 0.0 108.602 -174.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 76.1 m -128.68 147.77 50.77 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.893 0.877 . . . . 0.0 109.232 175.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.0 mtpt -140.21 148.97 42.33 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.011 1.324 . . . . 0.0 108.884 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.077 0 O-C-N 122.335 -0.228 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 N--CA 1.474 0.727 0 N-CA-C 111.215 0.08 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.9 m -142.03 164.75 29.33 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.983 0.913 . . . . 0.0 110.01 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.7 p-80 -158.54 167.43 29.62 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.111 1.364 . . . . 0.0 108.935 -175.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -80.76 140.79 35.33 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 172.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -151.24 -167.4 14.74 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -177.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.0 -34.07 39.52 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.408 2.739 . . . . 0.0 111.918 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.8 mt -99.1 60.46 1.2 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.4 -129.81 45.79 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 71.8 t-105 -85.2 109.92 18.65 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 68.6 t -99.81 125.89 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 124.764 1.225 . . . . 0.0 108.726 -175.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 39.9 m -99.76 133.15 44.53 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.488 0.715 . . . . 0.0 109.968 175.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -88.46 66.55 8.31 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.811 1.244 . . . . 0.0 109.232 -172.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.065 0 CA-C-N 116.45 -0.341 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 N--CA 1.474 0.773 0 N-CA-C 111.828 0.306 . . . . 0.0 111.828 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 61.9 m -83.54 -175.82 6.0 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.97 0.908 . . . . 0.0 109.687 173.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.3 p-80 -147.49 168.92 20.7 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.621 0.769 . . . . 0.0 110.986 -169.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -85.4 122.51 29.66 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 171.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -139.81 -165.7 10.37 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.752 1.168 . . . . 0.0 110.716 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 99.5 Cg_exo -49.58 -48.26 19.7 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 124.865 3.71 . . . . 0.0 113.978 -176.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.2 mt -99.26 61.62 1.22 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.603 0.761 . . . . 0.0 109.075 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.36 -117.92 12.39 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 177.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 63.0 t-105 -87.36 97.53 10.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.2 t -99.77 132.69 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 125.096 1.359 . . . . 0.0 109.2 -174.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 96.6 m -99.66 144.03 29.21 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.058 0.943 . . . . 0.0 109.436 175.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.44 161.3 26.2 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.837 0.855 . . . . 0.0 110.886 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.063 0 O-C-N 122.21 -0.307 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.3 p . . . . . 0 N--CA 1.474 0.729 0 CA-C-O 120.347 0.118 . . . . 0.0 111.043 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 11.8 m -138.29 163.53 31.55 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.911 0.884 . . . . 0.0 110.156 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 -152.51 157.89 41.76 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.733 1.213 . . . . 0.0 109.303 -173.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -73.77 92.91 2.06 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 173.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -92.92 -166.49 38.62 Favored Glycine 0 CA--C 1.532 1.109 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 173.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -63.63 -36.14 54.72 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.163 2.575 . . . . 0.0 111.829 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.8 mt -99.45 53.2 0.94 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.747 0.819 . . . . 0.0 109.579 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.83 -134.19 40.76 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -68.34 100.47 1.07 Allowed 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 117.37 0.585 . . . . 0.0 109.959 174.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 70.8 t -99.46 125.44 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 173.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 95.0 m -99.83 139.34 35.63 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.967 0.907 . . . . 0.0 110.596 -177.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -155.72 91.11 1.27 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.075 0 O-C-N 122.186 -0.321 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.7 t . . . . . 0 N--CA 1.474 0.734 0 N-CA-C 111.347 0.129 . . . . 0.0 111.347 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.3 m -87.72 156.85 19.24 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.456 0.646 . . . . 0.0 110.414 169.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.7 p-80 -160.05 160.09 32.75 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.915 2.086 . . . . 0.0 107.125 -172.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -71.99 128.68 36.49 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 176.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -149.64 -168.03 14.65 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.475 1.036 . . . . 0.0 110.543 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -50.4 -48.93 18.1 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 124.851 3.701 . . . . 0.0 113.759 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.3 mt -99.22 59.22 1.13 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.597 0.759 . . . . 0.0 109.084 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 65.67 -113.83 6.12 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 124.031 0.824 . . . . 0.0 111.109 176.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 39.6 t-105 -96.46 93.76 7.0 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.447 1.099 . . . . 0.0 108.621 -177.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 64.5 t -99.68 132.53 44.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.157 0 C-N-CA 125.076 1.35 . . . . 0.0 109.691 -169.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.5 m -99.97 138.7 36.68 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.734 1.214 . . . . 0.0 109.454 169.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -81.2 64.84 6.1 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.508 1.123 . . . . 0.0 109.844 176.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.083 0 O-C-N 122.061 -0.399 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 57.7 p . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 111.528 0.195 . . . . 0.0 111.528 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 98.7 m -81.46 99.94 9.03 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.221 1.408 . . . . 0.0 110.652 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -139.73 165.66 26.68 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 126.072 1.749 . . . . 0.0 108.478 176.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -78.06 133.56 37.89 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 172.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -149.18 -163.61 11.08 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -51.69 -44.74 42.48 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 124.735 3.623 . . . . 0.0 113.779 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.5 mt -99.05 60.38 1.2 Allowed 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.545 0.738 . . . . 0.0 109.02 -176.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 62.01 -117.75 12.45 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -88.39 127.47 35.5 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 172.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 65.1 t -122.83 109.89 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 125.003 1.321 . . . . 0.0 108.761 -170.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 64.8 m -99.36 86.65 3.44 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.508 1.123 . . . . 0.0 108.731 173.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -79.82 76.52 6.5 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.43 1.092 . . . . 0.0 108.837 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.057 0 O-C-N 122.115 -0.365 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 44.0 m . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 111.287 0.106 . . . . 0.0 111.287 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 94.9 m -88.95 112.86 23.84 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.7 1.2 . . . . 0.0 109.201 174.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -148.84 163.92 35.99 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.421 1.088 . . . . 0.0 109.892 -175.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -73.88 94.8 2.35 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 174.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -103.57 -169.12 25.57 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.05 1.31 . . . . 0.0 110.612 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -64.17 -37.35 42.07 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 123.327 2.684 . . . . 0.0 111.693 -178.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 78.5 mt -99.43 54.7 0.96 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.725 0.81 . . . . 0.0 109.364 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.46 -125.92 18.18 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 174.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 49.5 t-105 -87.17 97.1 10.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 89.8 t -99.56 110.77 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 124.64 1.176 . . . . 0.0 109.042 -170.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 93.4 m -99.71 104.53 16.26 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.548 1.539 . . . . 0.0 109.672 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -79.69 72.68 6.39 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 171.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.054 0 O-C-N 122.162 -0.336 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 48.0 p . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 119.848 -0.12 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 84.0 m -141.86 129.63 21.68 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.294 1.438 . . . . 0.0 109.335 177.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.6 p-80 -120.66 142.99 48.95 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 124.586 1.154 . . . . 0.0 108.014 171.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -72.99 141.95 47.74 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.27 -163.43 15.03 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -176.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -51.93 -45.04 41.12 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 124.665 3.577 . . . . 0.0 113.592 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.8 mt -99.14 60.54 1.2 Allowed 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.659 0.784 . . . . 0.0 108.95 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.68 -128.71 48.3 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -80.66 116.39 20.65 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 170.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.8 t -99.14 105.15 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -178.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 60.1 m -102.93 159.24 15.68 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.569 1.148 . . . . 0.0 111.19 -175.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.5 166.77 31.65 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.225 1.01 . . . . 0.0 110.242 178.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.069 0 O-C-N 122.283 -0.261 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.474 0.73 0 CA-C-O 120.722 0.296 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 63.5 m -79.86 153.87 28.77 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.318 0.647 . . . . 0.0 110.183 -178.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.2 p-80 -102.03 150.05 23.63 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.197 0.999 . . . . 0.0 108.421 170.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -78.01 91.38 4.24 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -97.87 -165.96 31.7 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.065 1.317 . . . . 0.0 110.939 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -52.3 -45.31 40.29 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 124.643 3.562 . . . . 0.0 113.068 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 72.3 mt -99.4 52.44 0.94 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.854 0.862 . . . . 0.0 109.542 -177.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 65.67 -136.83 36.38 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 178.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -73.77 96.9 2.62 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.049 0.54 . . . . 0.0 110.436 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 83.9 t -99.71 123.86 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 125.323 1.449 . . . . 0.0 108.331 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.7 m -99.28 157.88 16.08 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.105 0.962 . . . . 0.0 109.236 172.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -83.22 71.03 10.21 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.736 1.214 . . . . 0.0 108.736 -175.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.049 0 O-C-N 122.207 -0.308 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 N--CA 1.473 0.702 0 CA-C-O 120.775 0.321 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 70.0 m -79.92 149.71 30.8 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.357 0.663 . . . . 0.0 110.393 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.5 p-80 -95.35 149.25 21.57 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 124.451 1.101 . . . . 0.0 108.268 169.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -73.33 136.46 44.47 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -156.77 -165.02 14.17 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -176.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -50.82 -47.78 23.75 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 124.808 3.672 . . . . 0.0 113.678 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.8 mt -99.19 61.45 1.23 Allowed 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.46 -118.74 15.81 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 178.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -89.67 104.58 17.13 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.882 0.873 . . . . 0.0 109.428 175.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 64.7 t -99.89 121.56 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 125.328 1.451 . . . . 0.0 108.812 -176.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.7 m -99.3 161.8 13.41 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.785 0.834 . . . . 0.0 109.007 171.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -150.09 163.69 37.52 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.688 1.195 . . . . 0.0 109.577 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.086 0 O-C-N 122.287 -0.258 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 120.368 0.127 . . . . 0.0 111.303 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 40.1 m -79.76 167.89 20.03 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.22 0.608 . . . . 0.0 110.914 -178.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 39.8 p-80 -157.04 172.17 19.15 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.922 1.289 . . . . 0.0 109.084 -169.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -91.09 135.48 33.73 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 171.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -152.91 -165.02 12.95 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -178.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -50.7 -45.92 32.82 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 124.893 3.729 . . . . 0.0 114.181 -176.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -98.94 65.93 1.53 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 59.58 -121.55 27.08 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 176.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -85.58 106.08 16.62 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 174.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.8 t -99.88 126.35 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 124.913 1.285 . . . . 0.0 108.832 -175.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.2 m -99.69 163.02 12.66 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.975 0.91 . . . . 0.0 110.595 176.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.19 167.51 25.79 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.775 1.23 . . . . 0.0 109.761 177.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.094 0 O-C-N 122.238 -0.289 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 111.272 0.101 . . . . 0.0 111.272 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 11.9 m -81.81 143.74 31.55 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.367 0.667 . . . . 0.0 111.705 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.4 p-80 -150.9 165.84 32.42 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.057 1.743 . . . . 0.0 108.235 -176.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -75.06 81.53 2.24 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.198 0.599 . . . . 0.0 109.798 177.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -89.88 -163.31 39.1 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.485 1.517 . . . . 0.0 110.754 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -66.53 -42.7 9.08 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.275 2.65 . . . . 0.0 111.625 -174.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 73.1 mt -99.51 49.47 0.94 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.796 0.838 . . . . 0.0 109.649 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 73.39 -128.72 11.71 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 176.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 36.9 t-105 -83.07 80.92 8.9 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.66 0.784 . . . . 0.0 109.995 -173.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.6 t -99.6 134.32 39.29 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 124.946 1.298 . . . . 0.0 109.453 -171.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.6 m -99.13 132.76 44.21 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.324 1.45 . . . . 0.0 109.894 177.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -138.24 163.43 31.77 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.491 1.516 . . . . 0.0 108.302 171.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.065 0 O-C-N 122.206 -0.309 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 78.1 p . . . . . 0 N--CA 1.474 0.75 0 CA-C-O 120.251 0.072 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.8 m -97.81 156.37 16.61 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 123.896 0.879 . . . . 0.0 112.207 -178.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.2 p-80 -159.63 162.01 35.12 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 127.101 2.16 . . . . 0.0 107.316 -170.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -73.85 123.44 24.22 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -135.61 -170.38 12.08 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.311 1.434 . . . . 0.0 110.198 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -65.5 -35.57 38.16 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.543 2.829 . . . . 0.0 112.34 -175.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -99.03 61.21 1.24 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 176.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 64.03 -115.29 7.73 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.163 0.887 . . . . 0.0 111.51 175.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 45.8 t-105 -98.24 93.84 6.45 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.416 1.086 . . . . 0.0 108.696 -177.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 96.4 t -99.69 136.89 28.99 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.124 0 C-N-CA 125.038 1.335 . . . . 0.0 109.487 -170.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.7 m -99.92 147.49 25.5 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.45 1.1 . . . . 0.0 110.615 171.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -79.78 75.82 6.46 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.321 1.048 . . . . 0.0 109.184 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.095 0 O-C-N 122.126 -0.359 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 65.6 p . . . . . 0 N--CA 1.474 0.74 0 N-CA-C 111.416 0.154 . . . . 0.0 111.416 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.6 m -140.6 155.91 46.43 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.555 0.742 . . . . 0.0 110.367 174.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 -160.41 160.82 32.69 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.644 1.578 . . . . 0.0 108.016 -173.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -77.67 137.75 38.69 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -156.98 -164.21 13.31 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -178.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -50.87 -45.78 34.11 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 124.848 3.699 . . . . 0.0 113.861 -176.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.6 mt -99.08 61.58 1.25 Allowed 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -176.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.35 -121.21 25.87 Favored Glycine 0 C--N 1.34 0.756 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 178.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 65.2 t-105 -86.48 108.99 18.77 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 174.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.6 t -99.48 115.82 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 125.069 1.347 . . . . 0.0 108.849 -173.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 43.2 m -99.5 88.26 3.82 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.319 1.047 . . . . 0.0 109.198 176.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -139.22 154.34 48.0 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.033 1.333 . . . . 0.0 108.437 174.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.082 0 O-C-N 122.144 -0.348 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 N--CA 1.472 0.656 0 N-CA-C 111.257 0.095 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 95.9 m -87.03 105.92 17.48 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.934 1.294 . . . . 0.0 109.582 176.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -145.51 164.18 32.41 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 125.965 1.706 . . . . 0.0 108.474 -178.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -79.65 134.54 36.44 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 171.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -150.31 -164.4 11.85 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -177.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -52.21 -44.24 47.57 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 124.699 3.599 . . . . 0.0 113.678 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.9 mt -99.1 60.2 1.19 Allowed 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.617 0.767 . . . . 0.0 108.977 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.71 -119.18 17.2 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 62.5 t-105 -88.32 130.62 35.08 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 172.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.9 t -124.91 107.36 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 125.306 1.443 . . . . 0.0 108.782 -170.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 63.3 m -99.2 83.18 2.82 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 124.818 1.247 . . . . 0.0 108.303 171.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -79.98 79.05 6.57 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.152 0.981 . . . . 0.0 108.616 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.091 0 O-C-N 122.237 -0.29 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.472 0.639 0 CA-C-O 119.93 -0.081 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 91.9 m -89.03 105.66 17.93 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.717 1.207 . . . . 0.0 109.266 175.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 -145.65 160.79 41.17 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 125.727 1.611 . . . . 0.0 108.368 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -76.75 135.0 38.99 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 173.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -152.81 -163.72 11.9 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -177.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -51.73 -44.48 44.27 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 124.774 3.649 . . . . 0.0 113.762 -176.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.7 mt -99.05 60.31 1.2 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -176.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.96 -118.26 14.44 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 63.1 t-105 -88.8 126.29 35.28 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 172.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.2 t -120.08 104.79 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 125.263 1.425 . . . . 0.0 109.055 -170.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 70.3 m -99.38 81.26 2.51 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 125.01 1.324 . . . . 0.0 108.086 171.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -141.58 147.22 37.32 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 124.524 1.13 . . . . 0.0 109.119 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.083 0 O-C-N 122.198 -0.314 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 94.8 p . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 111.439 0.162 . . . . 0.0 111.439 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 92.3 m -142.39 142.43 32.41 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 124.555 1.142 . . . . 0.0 109.048 173.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.1 p-80 -160.51 162.21 32.98 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.488 1.115 . . . . 0.0 109.764 -169.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -77.25 97.55 4.86 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 171.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.49 -167.28 29.88 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.044 1.307 . . . . 0.0 110.512 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -65.12 -37.21 33.53 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.246 2.631 . . . . 0.0 111.609 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.1 mt -99.4 54.32 0.96 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.761 0.824 . . . . 0.0 109.482 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.39 -133.12 23.54 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 175.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 61.8 t-105 -80.53 96.01 6.67 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.5 t -99.48 137.39 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 124.907 1.283 . . . . 0.0 108.543 -175.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 77.6 m -119.79 145.85 46.22 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.46 1.104 . . . . 0.0 109.962 176.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -141.34 150.58 42.66 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.153 1.381 . . . . 0.0 108.983 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.081 0 O-C-N 122.199 -0.313 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 46.0 m . . . . . 0 N--CA 1.475 0.782 0 CA-C-O 119.768 -0.158 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 74.0 m -140.69 147.87 39.91 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.19 0.996 . . . . 0.0 109.681 174.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.7 p-80 -160.41 162.5 33.3 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.695 1.198 . . . . 0.0 109.656 -169.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -77.12 97.1 4.63 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 172.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.63 -167.99 29.82 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.973 1.273 . . . . 0.0 110.539 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -64.93 -37.37 34.33 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.333 2.689 . . . . 0.0 111.602 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.2 mt -99.38 54.41 0.96 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.791 0.837 . . . . 0.0 109.486 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.39 -132.16 22.75 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 175.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -81.27 96.09 7.17 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 95.2 t -99.5 140.94 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 124.8 1.24 . . . . 0.0 108.542 -175.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 79.0 m -122.87 149.18 44.54 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.448 1.099 . . . . 0.0 110.414 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -142.97 148.11 36.3 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.485 1.514 . . . . 0.0 108.624 177.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 -0.013 0 O-C-N 122.214 -0.304 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 42.8 m . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 37.3 m -139.68 168.08 20.64 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.83 0.852 . . . . 0.0 110.176 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 27.9 p-80 -160.05 171.56 19.1 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.911 1.284 . . . . 0.0 109.263 -169.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -87.96 138.85 31.09 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 170.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -150.07 -168.25 15.04 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -65.84 -34.1 40.83 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.442 2.762 . . . . 0.0 112.369 -175.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -98.97 63.48 1.36 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 176.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.2 -128.08 43.63 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 176.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -84.34 105.98 15.59 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 175.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.1 t -99.96 131.83 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 124.651 1.18 . . . . 0.0 108.807 -176.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 47.0 m -99.43 146.35 26.43 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.273 0.629 . . . . 0.0 110.245 177.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -82.51 69.9 9.37 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.275 1.03 . . . . 0.0 109.688 -173.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.085 0 O-C-N 122.151 -0.343 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 42.3 m . . . . . 0 N--CA 1.474 0.732 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.7 m -138.26 145.76 41.71 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.847 0.859 . . . . 0.0 109.967 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.9 p-80 -121.9 144.94 48.56 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.773 1.629 . . . . 0.0 107.806 176.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -71.62 142.63 49.96 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.8 -163.7 16.09 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -176.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -51.98 -45.77 36.62 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 124.706 3.604 . . . . 0.0 113.546 -177.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 76.4 mt -99.19 61.28 1.22 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.673 0.789 . . . . 0.0 108.968 -176.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.97 -128.07 46.81 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -81.15 115.82 20.76 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 170.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 67.0 t -99.15 114.87 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 96.8 m -99.51 144.29 28.77 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.007 0.923 . . . . 0.0 111.044 -171.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -80.14 73.9 6.95 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.229 1.011 . . . . 0.0 109.32 -177.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.056 0 O-C-N 122.069 -0.394 . . . . 0.0 . . . . . . . . . . 0 0 . 1 stop_ save_